NYSE - Nasdaq Real Time Price USD
Penumbra, Inc. (PEN)
As of 10:05 AM EST. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 12 | 17 | 17 |
| Avg. Estimate | 0.88 | 0.71 | 2.77 | 3.76 |
| Low Estimate | 0.74 | 0.55 | 2.63 | 3.31 |
| High Estimate | 1.08 | 1.05 | 2.99 | 4.44 |
| Year Ago EPS | 0.76 | 0.41 | 2.09 | 2.77 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 10 | 17 | 17 |
| Avg. Estimate | 311.57M | 317.17M | 1.19B | 1.36B |
| Low Estimate | 305.9M | 306.13M | 1.19B | 1.32B |
| High Estimate | 317.11M | 324.6M | 1.2B | 1.39B |
| Year Ago Sales | 284.68M | 278.65M | 1.06B | 1.19B |
| Sales Growth (year/est) | 9.45% | 13.82% | 12.47% | 14.45% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.7 | 0.38 | 0.56 | 0.69 |
| EPS Actual | 0.76 | 0.41 | 0.64 | 0.85 |
| Difference | 0.06 | 0.03 | 0.08 | 0.16 |
| Surprise % | 8.62% | 8.28% | 14.79% | 23.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.88 | 0.71 | 2.77 | 3.76 |
| 7 Days Ago | 0.88 | 0.71 | 2.77 | 3.76 |
| 30 Days Ago | 0.85 | 0.7 | 2.59 | 3.55 |
| 60 Days Ago | 0.85 | 0.71 | 2.59 | 3.56 |
| 90 Days Ago | 0.86 | 0.7 | 2.62 | 3.57 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 8 | 3 | 12 | 10 |
| Up Last 30 Days | 9 | 4 | 13 | 11 |
| Down Last 7 Days | 2 | 2 | -- | 2 |
| Down Last 30 Days | 3 | 3 | -- | 3 |
Growth Estimates
| CURRENCY IN USD | PEN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 16.00% | -- | -- | 5.00% |
| Next Qtr. | 71.97% | -- | -- | 12.00% |
| Current Year | 32.64% | -- | -- | 2.10% |
| Next Year | 35.80% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 11/20/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/31/2024 |
| Reiterates | Needham: Hold | 10/31/2024 |
| Maintains | Baird: Outperform to Outperform | 10/31/2024 |
| Reiterates | Needham: Hold | 10/25/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 10/18/2024 |
Related Tickers
IRTC iRhythm Technologies, Inc.
72.84
-1.23%
NVRO Nevro Corp.
4.2500
+0.47%
NARI Inari Medical, Inc.
49.20
+0.41%
SGHT Sight Sciences, Inc.
3.7300
0.00%
INSP Inspire Medical Systems, Inc.
184.41
-0.19%
BSX Boston Scientific Corporation
90.92
+0.83%
PODD Insulet Corporation
263.53
-1.14%
LIVN LivaNova PLC
49.76
-0.58%
MASI Masimo Corporation
166.29
+0.81%
GKOS Glaukos Corporation
142.62
+0.83%